tradingkey.logo

Alpha Teknova Inc

TKNO
View Detailed Chart

4.640USD

+0.240+5.45%
Close 09/18, 16:00ETQuotes delayed by 15 min
248.31MMarket Cap
LossP/E TTM

Alpha Teknova Inc

4.640

+0.240+5.45%
Intraday
1m
30m
1h
D
W
M
D

Today

+5.45%

5 Days

+17.17%

1 Month

-1.07%

6 Months

-17.88%

Year to Date

-44.43%

1 Year

-2.73%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
66 / 207
Overall Ranking
197 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 6 analysts
Buy
Current Rating
10.000
Target Price
+121.24%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
Growing
The company is in a growing phase, with the latest annual income totaling USD 37.74M.
Undervalued
The company’s latest PE is -11.11, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.86M shares, decreasing 1.79% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 652.18K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.20.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
Ticker SymbolTKNO
CompanyAlpha Teknova Inc
CEOMr. Stephen Gunstream
Websitehttps://www.teknova.com/
KeyAI